Martha Bustos allegedly helped a friend gain millions by tipping him off with confidential information in advance of Illumina's quarterly reports.
The award will help fund development of the firm's "ksim" algorithm to determine infection relatedness in suspected hospital-acquired infection outbreaks.
Researchers characterized new and known cell populations with single-cell transcriptome profiles for nearly 10,400 liver cells, using the data to see changes associated with liver cancer.
The partnership brings Mission Bio's Tapestri NGS-based single-cell sequencing platform for cancer profiling to the Chinese market.
The company had a profit of £3.4 million, or £0.01 per share, for the year compared to a loss of £9.6 million, or £0.03 per share, the previous year.
Five hundred pharmacies will provide information about pharmacogenetic testing to members who have failed one or more antidepressant treatments.
One BioMed was spun out of Singapore's Agency for Science, Technology, and Research to develop a point-of-care diagnostic platform for infectious disease.
Celsius Therapeutics uses single-cell genomic sequencing and informatics to discover new therapies for autoimmune disease and cancer.
Tabula Rasa Healthcare will deliver pharmacogenomics test results from CQuentia's lab, while CQuentia will supply analytics and biometric wearables.
Forensic laboratories can now use the Applied Biosystems Precision ID System mtDNA analysis to submit profiles to a national database.
The investment firm also reduced its price target to $30 per share from $37 citing "lower overall conviction" that Myriad would meet its revenue projections.
Under the agreement, Biodesix will use the Thermo Fisher Ion Torrent Oncomine Pan-Cancer Cell-Free Assay to generate data to apply for FDA premarket approval.
The deal covers Arcis' line of nucleic acid extraction and preservation products, which enable RNA and DNA preparation in under three minutes.
Nasdaq told the company that its shares have failed to meet a minimum $1 per share closing price for 30 consecutive days and may face delisting action.
Some of the loci suggest potential treatment options with drugs that modulate LDL cholesterol, the LPL pathway, or circulating lipoprotein(a), the researchers said.
In a message posted on Twitter today, Oxford Nanopore said that revenues grew to $43.7 million last year, up from $17.8 million in 2017.
The researchers found that while BMI broadly increased over time in their Norwegian cohort, genetically predisposed individuals were more highly affected.
The partners are working together to advance tests that will identify which cancer patients have Notch activating mutations and fusions.
The project, called Seq&Treat, will be implemented in Brazil, China, Georgia, India, and South Africa starting in October.
By sequencing 10 Bronze, early Iron, and late Iron Age individuals, researchers retraced ancestry patterns at a Philistine port city in present-day Israel.
From single-cell RNA sequence data on neurogenic brain samples from young and old mice, researchers saw T cell activity that seems to staunch neural stem cell proliferation.
The work is being conducted as part of the Human Cell Atlas initiative, which was launched in 2016 to create a reference atlas of all human cell types.
The companies will combine their respective technologies to offer genomic services for the plant and animal breeding sectors.
The firm plans to address the fact that only 2 percent of human DNA samples used in pharmaceutical research are from Africans or those of African ancestry.
A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.
A new analysis finds some cancers receive more nonprofit dollars than others.
An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.
In Science this week: comparative analysis of sex differences in mammal gene expression, and more.